5-amino-1mq and cd38 inhibitor synergy nad+ Targeting CD38-dependent metabolism to mitigate multiple organ fibrosis The Pharmacology of CD38/NADase: An
The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC NAD+ metabolism and its roles in cellular processes during ageing PMC SLC25A51 decouples the mitochondrial NAD+ NADH ratio to control proliferation of AML cells: Cell Metabolism Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline: Cell Metabolism Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS driven AML: Cell Metabolism
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5





